{"id":15263,"date":"2023-01-16T04:00:00","date_gmt":"2023-01-16T04:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3985188_AE85188_0"},"modified":"2023-01-16T04:00:00","modified_gmt":"2023-01-16T04:00:00","slug":"mgi-demonstrates-strong-commitment-to-expanding-genomic-access-in-europe","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=15263","title":{"rendered":"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" class=\"ff-og-image-inserted\"><\/div>\n<div id=\"dvContent\" readability=\"146.90460739779\">\n<p><span class=\"xn-location\">SHENZHEN, China<\/span>, <span class=\"xn-chron\">Jan. 16, 2023<\/span> \/PRNewswire\/ &#8212;&nbsp;Thanks to initiatives such as the 1+ Million Genomes, world-class academic and public research funding, as well as extensive regulatory and clinical applications, <span class=\"xn-location\">Europe<\/span> has become a top genomics market and technology leader. With a commitment to building core tools and technology to lead life science, MGI Tech Co., Ltd. (or its affiliates, referred to as &#8220;<b><a href=\"https:\/\/en.mgi-tech.com\/\" target=\"_blank\" rel=\"nofollow noopener\">MGI<\/a><\/b>&#8220;) is dedicated to enhancing access across the continent.<\/p>\n<p>This past year, MGI expanded its presence in <span class=\"xn-location\">Europe<\/span> first by introducing the latest HotMPS* sequencing chemistry in selected countries in April. It later became commercially available in the <span class=\"xn-location\">United Kingdom<\/span> and <span class=\"xn-location\">Germany<\/span> in July and September respectively. Built upon the combinatorial Probe Anchor Synthesis (cPAS) technology found in MGI&#8217;s DNBSEQ\u2122 technology***, HotMPS* presents significant advantages including stronger signal, less systematic sequence-based errors.<\/p>\n<p>Shortly after that, a new central office was set up in Wehrheim, <span class=\"xn-location\">Germany<\/span> in July and MGI&#8217;s first overseas Customer Experience Center (CEC) was opened in <span class=\"xn-location\">Latvia<\/span> in October, followed by two other CECs in <span class=\"xn-location\">London<\/span> and <span class=\"xn-location\">Berlin<\/span> in November. &#8220;MGI&#8217;s latest product* roll-out and expansion in <span class=\"xn-location\">Europe<\/span> demonstrate our commitment to and staying power in the market,&#8221; said Dr. <span class=\"xn-person\">Yong Hou<\/span>, General Manager of MGI Europe and <span class=\"xn-location\">Africa<\/span>. &#8220;As we continue to introduce our proven technology*** and its benefits to more people in the region, we are also fostering closer ties with customers and partners, facilitating better understanding and knowledge of our products, and providing the right to another choice.&#8221;<\/p>\n<p>The Wehrheim office is home to most of MGI&#8217;s human resources personnel in <span class=\"xn-location\">Europe<\/span>, who is responsible for building out a smooth recruitment and expansion process to facilitate a rapidly growing business. In addition, warehouse facilities equipped with MGI&#8217;s cutting-edge technology*** are available to support the marketing, Field Application Specialist and Field Service Engineer teams.<\/p>\n<p>Meanwhile, joining existing MGI demo labs in <span class=\"xn-location\">Australia<\/span> and <span class=\"xn-location\">Japan<\/span>, the CEC in <span class=\"xn-location\">Riga<\/span> serves customers and partners by facilitating easier access to and expertise in high-throughput sequencing technology and specialized automation workflows. Besides running demo tests, the site offers validation for the compatibility of third-party products, while operating as a training center for MGI staff and distributors.<\/p>\n<p>On the other hand, the London CEC operated by partners from the BRC Genomics Facility at Imperial College London is equipped with MGI&#8217;s innovative automation and sequencing solutions***, including the UK&#8217;s first DNBSEQ-G400 sequencer**, to enable metagenomic analysis, spatial transcriptomics, microbiome, spatiotemporal omics, WGS, WES, RNA sequencing and more. Similarly, the CEC in <span class=\"xn-location\">Berlin<\/span> was the fruits of MGI&#8217;s partnership with leading precision network ALACRiS Theranostics GmbH (ALACRiS), which combines MGI&#8217;s strong technology platforms with ALACRiS&#8217;s unique clinical solutions to facilitate precision medicine for all on multiple cancer indications.<\/p>\n<p>&#8220;MGI&#8217;s three new CECs are providing customers and partners in <span class=\"xn-location\">Europe<\/span> with unique access to our cutting-edge offering,&#8221; said <span class=\"xn-person\">Duncan Yu<\/span>, President at MGI. &#8220;In addition, they play an instrumental role in facilitating new scientific workflows, amplifying knowledge across our sequencing and automation platforms, and further developing relevant capabilities and expertise across <span class=\"xn-location\">Europe<\/span>.&#8221;<\/p>\n<p>Since its inception in 2016, MGI has been at the forefront of genomics innovation, continuously pushing boundaries and exploring the limits of technology. MGI&#8217;s comprehensive product portfolio encompasses sequencing solutions*** based on DNBSEQ<sup>TM<\/sup>, automation systems, ultrasound diagnostic platforms and counting to meet the diverse needs of the industry. With applications across agriculture, population genomics, precision medicine and more, MGI empowers over 1,300 international users spanning 80 countries and regions.<\/p>\n<p>*This sequencing reagent is only available in selected countries.<\/p>\n<p>**This sequencer is only available in selected countries, and its software has been specially configured to be used in conjunction with MGI&#8217;s HotMPS sequencing reagents exclusively.<\/p>\n<p>***Unless otherwise informed, StandardMPS and CoolMPS sequencing reagents, and sequencers for use with such reagents are not available in <span class=\"xn-location\">Germany<\/span>, <span class=\"xn-location\">Spain<\/span>, UK, <span class=\"xn-location\">Sweden<\/span>, <span class=\"xn-location\">Belgium<\/span>, <span class=\"xn-location\">Italy<\/span>, <span class=\"xn-location\">Finland<\/span>, <span class=\"xn-location\">Czech Republic<\/span>, <span class=\"xn-location\">Switzerland<\/span>, <span class=\"xn-location\">Portugal<\/span>, <span class=\"xn-location\">Austria<\/span>, and <span class=\"xn-location\">Romania<\/span>. Unless otherwise informed, StandardMPS sequencing reagents, and sequencers for use with such reagents are not available in <span class=\"xn-location\">Hong Kong<\/span>.<\/p>\n<\/p><\/div>\n<p>Source: MGI Tech Co., Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SHENZHEN, China, Jan. 16, 2023 \/PRNewswire\/ &#8212;&nbsp;Thanks to initiatives such as the 1+ Million Genomes, world-class academic and public research funding, as well as extensive regulatory and clinical applications, Europe has become a top genomics market and technology leader. With a commitment to building core tools and technology to lead life science, MGI Tech Co., [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-15263","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=15263\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe - My Blog\" \/>\n<meta property=\"og:description\" content=\"SHENZHEN, China, Jan. 16, 2023 \/PRNewswire\/ &#8212;&nbsp;Thanks to initiatives such as the 1+ Million Genomes, world-class academic and public research funding, as well as extensive regulatory and clinical applications, Europe has become a top genomics market and technology leader. With a commitment to building core tools and technology to lead life science, MGI Tech Co., [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=15263\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-16T04:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe\",\"datePublished\":\"2023-01-16T04:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263\"},\"wordCount\":667,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263\",\"name\":\"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"datePublished\":\"2023-01-16T04:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#primaryimage\",\"url\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"contentUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=15263#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=15263","og_locale":"en_US","og_type":"article","og_title":"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe - My Blog","og_description":"SHENZHEN, China, Jan. 16, 2023 \/PRNewswire\/ &#8212;&nbsp;Thanks to initiatives such as the 1+ Million Genomes, world-class academic and public research funding, as well as extensive regulatory and clinical applications, Europe has become a top genomics market and technology leader. With a commitment to building core tools and technology to lead life science, MGI Tech Co., [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=15263","og_site_name":"My Blog","article_published_time":"2023-01-16T04:00:00+00:00","og_image":[{"url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=15263#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15263"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe","datePublished":"2023-01-16T04:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15263"},"wordCount":667,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15263#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=15263","url":"https:\/\/transmediavictoria.net.au\/?p=15263","name":"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15263#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15263#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","datePublished":"2023-01-16T04:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=15263#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=15263"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=15263#primaryimage","url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","contentUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=15263#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/15263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15263"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/15263\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}